Jun 4, 2026 07:30AM
Jun 2, 2026 06:10AM
May 26, 2026 07:32AM
May 19, 2026 07:30AM
May 15, 2026 04:05PM
May 8, 2026 07:30AM
May 7, 2026 07:30AM Plus Therapeutics subsidiary gets Medicare enrollment for diagnostic test
Apr 8, 2026 07:30AM
Apr 7, 2026 07:33AM
Apr 2, 2026 07:30AM
Mar 31, 2026 09:24AM
Mar 19, 2026 08:27AM
Jan 23, 2026 06:44AM
Jan 22, 2026 07:45AM Plus Therapeutics outlines 2026 goals for REYOBIQ trials and CNSide rollout
Jan 8, 2026 07:31AM
Dec 11, 2025 07:31AM
Dec 9, 2025 07:31AM
Nov 26, 2025 07:48AM
Nov 24, 2025 07:31AM
Nov 20, 2025 07:30AM
Nov 17, 2025 07:31AM Plus Therapeutics gets 180-day extension for NASDAQ compliance
Nov 3, 2025 06:46AM
Oct 30, 2025 05:54PM
Oct 21, 2025 07:31AM
Sep 25, 2025 07:30AM
Sep 22, 2025 07:30AM
Sep 18, 2025 07:31AM
Sep 3, 2025 07:02AM D. Boral Capital Upgrades Plus Therapeutics Inc. (PSTV) to Buy
Aug 26, 2025 07:31AM
Aug 15, 2025 01:42PM
Aug 15, 2025 07:30AM
Aug 14, 2025 05:24PM
Aug 14, 2025 07:32AM
Aug 12, 2025 04:09PM
Jul 31, 2025 07:32AM Plus Therapeutics launches CNSide diagnostic in Texas
Jul 23, 2025 07:30AM
Jul 15, 2025 07:31AM
Jul 8, 2025 07:31AM
Jun 30, 2025 07:30AM
Jun 27, 2025 06:49AM
Jun 26, 2025 07:31AM
Jun 25, 2025 07:30AM Plus Therapeutics (PSTV) Announces FDA Clearance of its Investigational New Drug Application using REYOBIQTM
Jun 24, 2025 07:32AM
Jun 20, 2025 06:17AM
Jun 18, 2025 06:04AM
Jun 5, 2025 06:23AM
May 23, 2025 04:27PM
May 14, 2025 07:31AM
Apr 23, 2025 08:02AM Plus Therapeutics (PSTV) Appoints Kyle Guse to its Board
Apr 15, 2025 07:30AM

416,816 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All